title: Contents of general practitioner-patient consultations in the treatment of depression.
abstract: BACKGROUND
  Counseling of patients is an indispensable part of any drug treatment and even more so in the treatment of depression.
  
  
  OBJECTIVE
  To describe the content of counseling additional to prescribing an antidepressant drug.
  
  
  METHODS
  Sixty-three general practices from all over Germany.
  
  
  METHODS
  Three hundred two patients with the diagnosis of either a depressive episode or a recurrent depressive disorder.
  
  
  METHODS
  Assessment of the content of the physician-patient encounter by content analysis following the pivotal topic method.
  
  
  METHODS
  Qualitative study embedded in a drug utilization study on mirtazapine.
  
  
  RESULTS
  In the initial sessions general practitioners focused on building a good therapeutic alliance, assessing the symptoms of illness, explaining the course of treatment, assuring medication compliance, and discussing problems of life. In the middle phase of treatment, physicians also dealt with building a therapeutic alliance, medication compliance, and the progress and course of illness. In the last phase relapse prevention was an important topic. Psychological topics were more important than medication topics. Almost no importance was given to management of side effects, change of cognitions, or suicidal tendencies.
  
  
  CONCLUSIONS
  No information is available on how content was actually discussed. Only encounters were observed where an antidepressant was prescribed.
  
  
  CONCLUSIONS
  Counseling plays an important part in day-to-day encounters of general practitioners. Pharmacotherapy is embedded in comprehensive psychological care. Training programs for general practitioners should be specific in respect to different tasks and parts of the physician-patient encounter (e.g., building a therapeutic alliance, support for life problems or change of cognitions).
authors.affiliation: Research Group Psychosomatic Rehabilitation, Charité University Medicine Berlin, Teltow/Berlin, Germany. michael.linden@charite.de
authors.forename: Michael
authors.initials: M
authors.lastname: Linden
authors.forename: Tatjana
authors.initials: T
authors.lastname: Christof
authors.forename: Christiane
authors.initials: C
authors.lastname: Rentzsch
mesh_terms: D003376:Counseling / Q000379:methods; D003866:Depressive Disorder / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D006801:Humans; D008803:Mianserin / Q000031:analogs & derivatives / Q000627:therapeutic use; D000078785:Mirtazapine; D010353:Patient Education as Topic / Q000379:methods; D010817:Physician-Patient Relations; D010821:Physicians, Family / Q000523:psychology; D013811:Psychotherapeutic Processes; D012017:Referral and Consultation; D016896:Treatment Outcome
chemical_list: D008803:Mianserin; D000078785:Mirtazapine